Longriver Investment Partners
Overview
An independent investment manager based in Hong Kong that runs a global equity strategy with a focus on value investing principles.
Portfolio Companies
2
Website
longriverinv.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Allorion Therapeutics | Mar 2023 | Series B | Co-investor |
| Sironax | Aug 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.